Preferential issue to promoter group revised down to 6.55 lakh shares

QIP at a premiumFund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.2%Reaction day

₹170.40

prior close

₹170.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-4.5% vs market

Pharmaceuticals peers, median of 173sector+0.5%-3.7% vs sector

On the reaction day the stock moved 4.5 pts less than Nifty Microcap 250 and 3.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

-1.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.2+1.3-4.5+0.5-3.7

Next day

-2.3-0.2-2.1-0.5-1.8

-6.8+0.1-6.9-0.1-6.7

-11.9-1.5-10.4-0.9-11.0

-13.1-0.5-12.6-0.4-12.7

-13.8-0.8-13.0-2.0-11.8

-13.3-2.0-11.3-3.1-10.2

15d

-12.9-3.4-9.5-4.8-8.0

-21.9-9.9-12.0-9.7-12.2

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kerala Ayurveda revised its preferential issue to promoter group entity Katra Holding from 7.20 lakh to 6.55 lakh equity shares at Rs 190.37 each, totaling about Rs 12.47 crore at a premium of Rs 180.37 over face value. Proceeds will partially adjust an existing unsecured loan of Rs 26.41 crore from Katra Holding. Post-issue, Katra Holding stake rises to 9.41% from 4.85%. This corrigendum updates the 34th AGM notice for September 28, 2026.

Likely market impact

Promoter group stake rises to 9.41%. Loan conversion reduces debt but causes minor dilution for existing shareholders.